Ascendis Pharma Files Routine 6-K Disclosure
Ticker: ASND · Form: 6-K · Filed: Apr 9, 2025 · CIK: 1612042
| Field | Detail |
|---|---|
| Company | Ascendis Pharma A/S (ASND) |
| Form Type | 6-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, routine-disclosure
Related Tickers: ASND
TL;DR
Ascendis Pharma (ASND) filed a 6-K, standard SEC disclosure, no major news.
AI Summary
Ascendis Pharma A/S filed a Form 6-K on April 9, 2025, to report information as a foreign private issuer. The filing does not contain specific financial figures or operational updates but serves as a routine disclosure to the SEC.
Why It Matters
This filing indicates Ascendis Pharma A/S is fulfilling its ongoing reporting obligations as a foreign private issuer with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not contain new material information that would typically impact risk.
Key Players & Entities
- Ascendis Pharma A/S (company) — Registrant
- 001-36815 (company) — SEC File Number
- 333-203040 (company) — Registration Number
- 333-210810 (company) — Registration Number
- 333-211512 (company) — Registration Number
- 333-213412 (company) — Registration Number
- 333-214843 (company) — Registration Number
- 333-216883 (company) — Registration Number
- 333-228576 (company) — Registration Number
FAQ
What type of filing is Ascendis Pharma A/S submitting?
Ascendis Pharma A/S is submitting a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Section 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the filing date of this Form 6-K?
This Form 6-K was filed on April 9, 2025.
What is the principal executive office address for Ascendis Pharma A/S?
The principal executive offices are located at Tuborg Boulevard 12, DK-2900 Hellerup, Denmark.
Does Ascendis Pharma A/S file annual reports under Form 20-F or 40-F?
Ascendis Pharma A/S files annual reports under Form 20-F.
What registration numbers are mentioned in the incorporation by reference section?
The registration numbers mentioned are 333-203040, 333-210810, 333-211512, 333-213412, 333-214843, 333-216883, and 333-228576, all on Form S-8.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 9, 2025 regarding Ascendis Pharma A/S (ASND).